Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Leica Biosystems

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Leica Biosystems

Regulatory records
1
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 1 FDA record to the applicant name Leica Biosystems. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Jun 4, 2026 to Jun 4, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code MVC appears in 1 of the 1 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P090015, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 36 Cherry Hill Dr., Danvers, MA, 01923. Recorded on P090015/S014, decision dated Jun 4, 2026.

Changes described in PMA records

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Product / regulatory recordCompanyPathwayDecision dateSource
Leica BiosystemsPMA supplementJun 4, 2026FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 20, 2026.